TIMM8A and cancer: Altogether, these results show that CBD induces the metallothionein pathway consistently in various cellular backgrounds, that this cellular response leads to enhanced MT expression which protects cancer cells against the DSF’s anticancer metabolite CuET, and that low levels of MTs render cancer cells more sensitive to CuET treatment, raising a possibility to explore MT levels as candidate biomarkers for future clinical applications.